DNA methylation changes associated with cancer risk factors and blood levels of vitamin metabolites in a prospective study

Epigenetics

Volumn 6, Issue 2, 2011, Pages 195-201

  Vineis, Paolo ^a,b   Chuang, Shu Chun ^a   Vaissière, Thomas ^c   Cuenin, Cyrille ^c   Ricceri, Fulvio ^b   Overvad, K ^f   Clavel Chapelon, F ^f   Linseisen, J ^f   Boeing, H ^f   Trichopoulou, A ^f   Lagiou, P ^f   Palli, D ^f   Pala, V ^f   Tumino, R ^f   Panico, S ^f   Bueno De Mesquita, H B ^f   Peeters, P H ^f   Lund, E ^f   Gonzalez, C A ^f   Molina, E ^f   Dorronsoro, M ^f   Barricarte, A ^f   Navarro, C ^f   Quiros, J R ^f   Manjer, J ^f   Jarvholm, B ^f   Key, T J ^f   Kaaks, R ^f   Riboli, E ^f   Johansson, Mattias ^c   Ueland, Per ^d,e   Brennan, Paul ^c   Herceg, Zdenko ^c   more..

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b Human Genetics Foundation (HuGeF)   (Italy)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^d UNIVERSITY OF BERGEN   (Norway)

^e HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^f NONE

Author keywords

Biomarkers; DNA methylation; Lung cancer; Prospective study; Risk factor exposures; Vitamin metabolites

Indexed keywords

CARBON; CYCLIN DEPENDENT KINASE INHIBITOR 2A; DRUG METABOLITE; FOLIC ACID; GENOMIC DNA; GLUTATHIONE TRANSFERASE P1; METHIONINE; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; VITAMIN; VITAMIN B GROUP;

ADULT; ARTICLE; BLOOD CELL; BLOOD SAMPLING; CANCER RISK; CARBON METABOLISM; CONTROLLED STUDY; CPG ISLAND; DIETARY INTAKE; DISEASE ASSOCIATION; DNA METHYLATION; EPIGENETICS; FEMALE; HUMAN; LIFESTYLE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SMOKING;

EID: 79951486681     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.6.2.13573     Document Type: Article

References (33)

1. IARC monographs on the evaluation of carcinogenic risks of chemicals to humans. Tobacco smoke and involuntary smoking. IARC monographs on the evaluation of carcinogenic risks to humans/World Health Organization, International Agency for Research on Cancer 2004; 83.
2. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nature reviews 2002; 3:415-28.
3. Herceg Z. Epigenetics and cancer: towards an evaluation of the impact of environmental and dietary factors. Mutagenesis 2007; 22:91-103.
4. Risch A, Plass C. Lung cancer epigenetics and genetics. Int J Cancer 2008; 123:1-7.
5. Vaissiere T, Hung RJ, Zaridze D, Moukeria A, Cuenin C, Fasolo V, et al. Quantitative analysis of DNA methylation profiles in lung cancer identifies aberrant DNA methylation of specific genes and its association with gender and cancer risk factors. Cancer Res 2009; 69:243-52.
6. Rauch TA, Zhong X, Wu X, Wang M, Kernstine KH, Wang Z, et al. High-resolution mapping of DNA hypermethylation and hypomethylation in lung cancer. Proc Natl Acad Sci USA 2008; 105:252-7.
7. Esteller M. Cancer epigenomics: DNA methylomes and histone-modification maps. Nat Rev 2007; 8:286-98.
8. Baccarelli A, Wright RO, Bollati V, Tarantini L, Litonjua AA, Suh HH, et al. Rapid DNA methylation changes after exposure to traffic particles. Am J Respir Crit Care Med 2009; 179:572-8.
9. Riboli E, Kaaks R. The EPIC Project: rationale and study design. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol 1997; 26:6-14.
10. Slimani N, Kaaks R, Ferrari P, Casagrande C, Clavel-Chapelon F, Lotze G, et al. European Prospective Investigation into Cancer and Nutrition (EPIC) calibration study: rationale, design and population characteristics. Public Health Nutr 2002; 5:1125-45.
11. Peluso M, Hainaut P, Airoldi L, Autrup H, Dunning A, Garte S, et al. Methodology of laboratory measurements in prospective studies on gene-environment interactions: the experience of GenAir. Mutat Res 2005; 574:92-104.
12. Johansson M, Relton C, Ueland PM, Vollset SE, Midttun O, Nygard O, et al. Serum B vitamin levels and risk of lung cancer. JAMA 2010; 303:2377-85.
13. Vaissiere T, Cuenin C, Paliwal A, Vineis P, Hoek G, Krzyzanowski M, et al. Quantitative analysis of DNA methylation after whole bisulfitome amplification of a minute amount of DNA from body fluids. Epigenetics 2009; 4:221-30.
14. Tost J, Dunker J, Gut IG. Analysis and quantification of multiple methylation variable positions in CpG islands by Pyrosequencing. BioTechniques 2003; 35:152-6.
15. Colella S, Shen L, Baggerly KA, Issa JP, Krahe R. Sensitive and quantitative universal Pyrosequencing methylation analysis of CpG sites. BioTechniques 2003; 35:146-50.
16. Yang AS, Estecio MR, Doshi K, Kondo Y, Tajara EH, Issa JP. A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements. Nucleic Acids Res 2004; 32:38.
17. Bock CT, Schranz P, Schroder CH, Zentgraf H. Hepatitis B virus genome is organized into nucleosomes in the nucleus of the infected cell. Virus Genes 1994; 8:215-29.
18. Ushijima T. Detection and interpretation of altered methylation patterns in cancer cells. Nat Rev Cancer 2005; 5:223-31.
19. James SJ, Melnyk S, Pogribna M, Pogribny IP, Caudill MA. Elevation in S-adenosylhomocysteine and DNA hypomethylation: potential epigenetic mechanism for homocysteine-related pathology. J Nutr 2002; 132:2361-6.
20. Niculescu MD, Zeisel SH. Diet, methyl donors and DNA methylation: interactions between dietary folate, methionine and choline. J Nutr 2002; 132:2333-5.
21. Junien C, Nathanielsz P. Report on the IASO Stock Conference 2006: early and lifelong environmental epigenomic programming of metabolic syndrome, obesity and type II diabetes. Obes Rev 2007; 8:487-502.
22. Widschwendter M, Apostolidou S, Raum E, Rothenbacher D, Fiegl H, Menon U, et al. Epigenotyping in peripheral blood cell DNA and breast cancer risk: a proof of principle study. PLoS ONE 2008; 3:e2656.
23. Aaroe J, Lindahl T, Dumeaux V, Saebo S, Tobin D, Hagen N, et al. Gene expression profiling of peripheral blood cells for early detection of breast cancer. Breast Cancer Res 2010; 12:7.
24. Tongbai R, Idelman G, Nordgard SH, Cui W, Jacobs JL, Haggerty CM, et al. Transcriptional networks inferred from molecular signatures of breast cancer. Am J Pathol 2008; 172:495-509.
25. Kim DH, Kim JS, Ji YI, Shim YM, Kim H, Han J, et al. Hypermethylation of RASSF1A promoter is associated with the age at starting smoking and a poor prognosis in primary non-small cell lung cancer. Cancer Res 2003; 63:3743-6.
26. Kersting M, Friedl C, Kraus A, Behn M, Pankow W, Schuermann M. Differential frequencies of p16(INK4a) promoter hypermethylation, p53 mutation and K-ras mutation in exfoliative material mark the development of lung cancer in symptomatic chronic smokers. J Clin Oncol 2000; 18:3221-9.
27. Seike M, Gemma A, Hosoya Y, Hemmi S, Taniguchi Y, Fukuda Y, et al. Increase in the frequency of p16INK4 gene inactivation by hypermethylation in lung cancer during the process of metastasis and its relation to the status of p53. Clin Cancer Res 2000; 6:4307-13.
28. Zochbauer-Muller S, Fong KM, Geradts J, Xu X, Seidl S, End-Pfutzenreuter A, et al. Expression of the candidate tumor suppressor gene hSRBC is frequently lost in primary lung cancers with and without DNA methylation. Oncogene 2005; 24:6249-55.
29. Dammann R, Li C, Yoon JH, Chin PL, Bates S, Pfeifer GP. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat Genet 2000; 25:315-9.
30. Pfeifer GP, Dammann R. Methylation of the tumor suppressor gene RASSF1A in human tumors. Biochemistry 2005; 70:576-83.
31. Fairfield KM, Fletcher RH. Vitamins for chronic disease prevention in adults: scientific review. JAMA 2002; 287:3116-26.
32. Metivier R, Gallais R, Tiffoche C, Le Peron C, Jurkowska RZ, Carmouche RP, et al. Cyclical DNA methylation of a transcriptionally active promoter. Nature 2008; 452:45-50.
33. Kangaspeska S, Stride B, Metivier R, Polycarpou-Schwarz M, Ibberson D, Carmouche RP, et al. Transient cyclical methylation of promoter DNA. Nature 2008; 452:112-5.